Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
iShares Bitcoin Trust
IBIT
|
+$1.07B |
| 2 |
T-Mobile US
TMUS
|
+$1.01B |
| 3 |
Nasdaq
NDAQ
|
+$644M |
| 4 |
Columbia Research Enhanced Core ETF
RECS
|
+$612M |
| 5 |
Dell
DELL
|
+$527M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$1.99B |
| 2 |
NVIDIA
NVDA
|
+$1.26B |
| 3 |
iShares Silver Trust
SLV
|
+$809M |
| 4 |
Microsoft
MSFT
|
+$724M |
| 5 |
CRWV
CoreWeave, Inc. Class A Common Stock
CRWV
|
+$711M |
Sector Composition
| 1 | Technology | 18.93% |
| 2 | Financials | 9.8% |
| 3 | Consumer Discretionary | 8.69% |
| 4 | Industrials | 8.25% |
| 5 | Communication Services | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4876
SELLAS Life Sciences
SLS
$178M
| $102K | ﹤0.01% |
46,682
-11,859
| -20% | -$26K |
|
4877
Jin Medical International
ZJYL
$88.2M
| $102K | ﹤0.01% |
157,128
-1,635
| -1% | -$1.06K |
|
4878
Horizon Technology Finance
HRZN
$281M
| $102K | ﹤0.01% |
+14,170
| New | +$102K |
|
|
NIOBW
4879
NioCorp Developments Ltd. Warrant
NIOBW
$48.1M
| $102K | ﹤0.01% |
201,049
| – | – |
|
4880
Foghorn Therapeutics
FHTX
$281M
| $102K | ﹤0.01% |
+21,622
| New | +$102K |
|
4881
Nuveen Municipal Value Fund
NUV
$1.85B
| $101K | ﹤0.01% |
+11,630
| New | +$101K |
|
|
PML
4882
PIMCO Municipal Income Fund II
PML
$515M
| $101K | ﹤0.01% |
+13,528
| New | +$101K |
|
4883
Dave Inc. Warrants
DAVEW
$14.2M
| $101K | ﹤0.01% |
55,598
-7
| -0% | -$13 |
|
4884
CPS Technologies
CPSH
$49.4M
| $98K | ﹤0.01% |
+35,379
| New | +$98K |
|
|
SLSR
4885
Solaris Resources
SLSR
$829M
| $97.2K | ﹤0.01% |
+21,188
| New | +$97.2K |
|
4886
Capitol Federal Financial
CFFN
$836M
| $96.1K | ﹤0.01% |
15,754
-193,750
| -92% | -$1.18M |
|
|
EFXT
4887
Enerflex
EFXT
$1.31B
| $95.8K | ﹤0.01% |
12,131
-660
| -5% | -$5.21K |
|
|
MFM
4888
MFS Municipal Income Trust
MFM
$220M
| $95.7K | ﹤0.01% |
+18,516
| New | +$95.7K |
|
4889
Alvotech Warrant
ALVOW
$323M
| $95.6K | ﹤0.01% |
56,260
-1
| -0% | -$2 |
|
4890
Oramed Pharmaceuticals
ORMP
$94.3M
| $95.3K | ﹤0.01% |
42,367
-24,806
| -37% | -$55.8K |
|
|
NIU
4891
Niu Technologies
NIU
$339M
| $95.3K | ﹤0.01% |
28,370
-281,195
| -91% | -$945K |
|
4892
Sidus Space
SIDU
$28.2M
| $95.2K | ﹤0.01% |
+55,046
| New | +$95.2K |
|
4893
Amprius Technologies
AMPX
$1.39B
| $94.1K | ﹤0.01% |
22,355
-83,628
| -79% | -$352K |
|
|
ELEV
4894
DELISTED
Elevation Oncology
ELEV
| $93.8K | ﹤0.01% |
255,443
+210,252
| +465% | +$77.2K |
|
|
CISO
4895
CISO Global
CISO
$42.8M
| $93.6K | ﹤0.01% |
+81,419
| New | +$93.6K |
|
4896
Arq
ARQ
$315M
| $93.4K | ﹤0.01% |
+17,388
| New | +$93.4K |
|
4897
Iterum Therapeutics
ITRM
$30.1M
| $92.5K | ﹤0.01% |
+92,943
| New | +$92.5K |
|
4898
PDS Biotechnology
PDSB
$54.5M
| $92.1K | ﹤0.01% |
+69,251
| New | +$92.1K |
|
|
OPP
4899
RiverNorth/DoubleLine Strategic Opportunity Fund
OPP
$205M
| $91.9K | ﹤0.01% |
+10,745
| New | +$91.9K |
|
4900
Gotham Short Strategies ETF
SHRT
$12.9M
| $91.3K | ﹤0.01% |
+11,399
| New | +$91.3K |
|